Merck attempts to reduce levels of carcinogenic compounds in diabetes drugs
Pharmafile
JANUARY 20, 2023
Pharmaceutical company Merck has announced that it is attempting to reduce levels of a cancer-causing compound which has been found in its popular type 2 diabetes drugs. The compound, known as nitrosamines or NTTP, often emerges from chemical reactions that can take place throughout the manufacturing process.
Let's personalize your content